ARCA biopharma and Oruka Therapeutics announce merger agreement
ARCA biopharma, Inc. (NASDAQ: ABIO) and Oruka Therapeutics have announced a definitive agreement to merge in an all-stock transaction, poised to reshape the chronic skin disease treatment landscape. The new entity, retaining the name Oruka Therapeutics, Inc., will focus on…